Inflammatory myopathies

A systematic approach to the consensus definitions and reliability of ultrasound in idiopathic inflammatory myopathies; Preliminary data by the OMERACT ultrasound in myositis working group

Semin Arthritis RheumPublished Delphi consensus study with reliability exercise

Authors' conclusion

The systematic approach by the OMERACT US in the myositis subgroup has developed a categorical morphological scoring system, which showed moderate inter-rater reliability using consensus-derived definitions of US domains in IIM.

Study context

Population
International experts from the OMERACT US in myositis subgroup; elementary US lesions in idiopathic inflammatory myopathies (IIM)
Participants
21 international experts
Outcome
Consensual definitions of elementary US lesions specific to IIM and their reliability
Methodological detailsmulticentre, multi-round Delphi survey, web-based reliability exercise
  • Multicentre
  • Multi-round Delphi survey
  • Web-based reliability exercise

Recommendations

As reported in the abstract

Reliability of the categorical morphological grading system (single domain "muscle inflammation and damage")

Intra-rater reliability, kappa (substantial; min 0.051, max 1.000, SD 0.295)

0.706

Inter-rater reliability, kappa (improved moderate; min 0.421, max 1.000, SD 0.167)

0.506

Further findings

Reliability of preliminary broad domains "inflammation" and "damage"

Intra-rater kappa, inflammation (substantial)
0.662
Intra-rater kappa, damage (substantial)
0.620
Inter-rater kappa, inflammation (poor)
0.142
Inter-rater kappa, damage (poor)
0.112

Original publication

A systematic approach to the consensus definitions and reliability of ultrasound in idiopathic inflammatory myopathies; Preliminary data by the OMERACT ultrasound in myositis working group. Semin Arthritis Rheum. Published 19 April 2026. doi:10.1016/j.semarthrit.2026.152984

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.